SMART therapy in adolescent and adults patients with moderate persistent asthma: a cost-utility analysis.

Jefferson Antonio BuendiaDiana Guerrero Patiño

Published in: The Journal of asthma : official journal of the Association for the Care of Asthma (2021)

SMART therapy was found to be cost-effective regarding fixed combination and fixed-dose inhaled corticosteroids. This evidence supports the use of SMART therapy in Colombia and must to be replicated in others middle-income countries.

Keyphrases

mental health
young adults
chronic obstructive pulmonary disease
stem cells
bone marrow
air pollution
childhood cancer
data analysis